H.R. 2123 (112th): Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011

Introduced:

Jun 3, 2011
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on June 3, 2011, in a previous session of Congress, but was not enacted.

Sponsor:

Elton Gallegly

Representative for California's 24th congressional district

Republican

Text:

Read Text »
Last Updated: Jun 3, 2011
Length: 16 pages

About the bill

Full Title

To amend the Public Health Service Act to improve the diagnosis and treatment of hereditary hemorrhagic telangiectasia, and for other purposes.

Read CRS summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 1167 (Related)
Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011

Referred to Committee
Last Action: Jun 9, 2011

What is a bill?

The “H.R.” in “H.R. 2123” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jun 3, 2011

Details

Cosponsors
34 cosponsors (26D, 8R) (show)
Committee Assignments
Health
Health

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: